Clinical trial
Evaluation of the Effect of an Infant Formula Containing Synbiotics on the Composition of the Gut Microbiota in Infants Born Via Caesarean Section
NCT04991792 is registered in ClinicalTrials.gov with HiPP GmbH & Co. Vertrieb KG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Effect of an Infant Formula Containing Synbiotics on the Composition of the Gut Microbiota in Infants Born Via Caesarean Section
- Lead sponsor
- HiPP GmbH & Co. Vertrieb KG
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 23, 2021
- Completion date
- July 7, 2024
- Enrollment
- 486 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gut microbiota